Emergency research and the interests of participants

@article{Pattinson2012EmergencyRA,
  title={Emergency research and the interests of participants},
  author={Shaun D Pattinson},
  journal={Medical Law International},
  year={2012},
  volume={12},
  pages={121 - 141}
}
  • S. Pattinson
  • Published 1 June 2012
  • Law
  • Medical Law International
The UK Clinical Trials Regulations were amended in 2006 and 2008 to facilitate research on medicinal products administered in emergency situations. The Regulations, which implement the EU Clinical Trials Directive, had previously required prior consent to participation in a clinical trial from either the participant or the participant’s legal representative. These amendments put emergency research on medicinal products on a similar footing to research on other types of invasive emergency… 
Involving adults who lack capacity in research: ethical and legal challenges for the pre-hospital and emergency medicine context.
TLDR
The paper goes on to explore how researchers can meet the legal requirement for research, how to frame the issues for the purposes of ethical review, as well as offering ethica...
The Principle of the Primacy of the Human Subject and Minimal Risk in Non-Beneficial Paediatric Research
TLDR
The paper argues for a new formula of the PP, and shows that it implies a specific non-comparative definition of the minimal risk threshold, and offers a new idea of how to reconcile the conduct of non-beneficial paediatric research with the PP.
Non-beneficial pediatric research: individual and social interests
TLDR
Not all, but only the most important interests of participants, must be guaranteed; this principle should be interpreted as the secure participant standard, and the issue of permissible risk ceiling becomes ethically crucial in research with incompetent subjects.
Taking the principle of the primacy of the human being seriously
TLDR
The proposed reading of the primacy principle is not only original, but also historically grounded and normatively fruitful, which provides a fresh and ethically rich perspective on the problem of an upper limit of permissible risks in non-beneficial studies.

References

SHOWING 1-10 OF 18 REFERENCES
The enforcement of morals: nontherapeutic research on children.
  • P. Ramsey
  • Psychology
    The Hastings Center report
  • 1976
TLDR
It is my contention that Richard McCormick's ethical analysis is incorrect, that it suffers from a moralistic quality, and that it is bound to weaken the protection of children in this age of research medicine.
New governance arrangements for research ethics committees: is facilitating research achieved at the cost of participants’ interest
TLDR
This paper examines the UK’s response to a recent European Clinical Trials Directive and argues that though the new arrangements go a long way toward addressing the uncertainty surrounding ethics committee function, the system favours the facilitation of research over the protection of the dignity and welfare of research participants.
Scientific research is a moral duty
  • John Harris
  • Political Science
    Journal of Medical Ethics
  • 2005
Biomedical research is so important that there is a positive moral obligation to pursue it and to participate in it Science is under attack. In Europe, America, and Australasia in particular,
The Value of Life: An Introduction to Medical Ethics
Like all John Harris's work, this survey and proposed solution of some of the central problems in medical ethics, especially life and death issues, is brilliantly argued (always) and highly
Consent and informational responsibility
TLDR
It is argued that whether or not such consent is treated as sufficiently informed must take account of four conditions, when applied to the operation of consent in relation to criminal responsibility for HIV transmission.
Thrombolysis during resuscitation for out-of-hospital cardiac arrest.
TLDR
When tenecteplase was used without adjunctive antithrombotic therapy during advanced life support for out-of-hospital cardiac arrest, it did not detect an improvement in outcome, in comparison with placebo.
The Case for Public Funding and Public Oversight of Clinical Trials
Clinical drug trials are public goods and should be publicly funded to avoid undersupply, the suppression of adverse results and other problems, according to Tracy R. Lewis, Jerome H. Reichman and
Nonfinancial conflicts of interest in research.
  • N. Levinsky
  • Education
    The New England journal of medicine
  • 2002
TLDR
How nonfinancial interests of investigators can be at odds with the interests of research subjects is explored and an approach to better management of nonfinancial conflicts of interest is outlined.
Ghost Marketing: Pharmaceutical Companies and Ghostwritten Journal Articles
TLDR
This article focuses on the type of ghostwriting that involves a pharmaceutical company hiring a medical education and communications company to write a paper favorable of their product and then hires a well-known academic to publish it under his or her name without disclosing the paper's true origins.
4) indicates that the cost of drug development ranged from US$92m to US$83.6m for out-of-pocket expenses
  • 2011
...
1
2
...